STATEMENTS OF CHANGES IN COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION AND STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)		Common stock subject to redemption Common stock	Common stock not subject to possible redemption Common stock	Additional Paid-in Capital	Accumulated Deficit	Total
Balance at the beginning at Feb. 24, 2021		$ 0	$ 0	$ 0	$ 0	$ 0
Balance at the beginning (in shares) at Feb. 24, 2021		0	0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock to Sponsor (1)	[1]		$ 575	32,758		33,333
Issuance of common stock to Sponsor (in shares)	[1]		5,750,000
Net income (loss)					(770)	(770)
Balance at the end at Mar. 31, 2021			$ 575	32,758	(770)	32,563
Balance at the end (in shares) at Mar. 31, 2021			5,750,000
Balance at the beginning at Feb. 24, 2021		$ 0	$ 0	0	0	0
Balance at the beginning (in shares) at Feb. 24, 2021		0	0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Excess fair value over consideration of the founder shares offered to the anchor investors						8,163,891
Remeasurement adjustment on redeemable common stock						(22,855,181)
Net income (loss)						(62,219)
Balance at the end at Sep. 30, 2021		$ 201,000,000	$ 575		(7,345,751)	(7,345,176)
Balance at the end (in shares) at Sep. 30, 2021		20,000,000	5,750,000
Balance at the beginning at Mar. 31, 2021			$ 575	32,758	(770)	32,563
Balance at the beginning (in shares) at Mar. 31, 2021			5,750,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)					7	7
Balance at the end at Jun. 30, 2021			$ 575	32,758	(763)	32,570
Balance at the end (in shares) at Jun. 30, 2021			5,750,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Sale of Class A common stock shares		$ 200,000,000
Sale of Class A common stock shares (in shares)		20,000,000
Deferred underwriting and advisory costs		$ (9,000,000)
Paid underwriting fees		(4,019,555)
Excess fair value over consideration of the founder shares offered to the anchor investors		(8,163,891)
Other offering costs paid		(671,735)
Excess fair value over consideration of the founder shares offered to the anchor investors					8,163,891	8,163,891
Sale of Private Placement Warrants				7,375,000		7,375,000
Remeasurement adjustment on redeemable common stock		22,855,181		$ (7,407,758)	(15,447,423)	(22,855,181)
Net income (loss)					(61,456)	(61,456)
Balance at the end at Sep. 30, 2021		$ 201,000,000	$ 575		$ (7,345,751)	$ (7,345,176)
Balance at the end (in shares) at Sep. 30, 2021		20,000,000	5,750,000

[1] (1) This number includes an aggregate of up to 750,000 common stock shares subject to forfeiture as of September 30, 2021 if the over-allotment option is not exercised in full or in part by the underwriters (see Notes 4 and 7).